CIK: 0001674546
Total reported value
$4.2B
Reporting period: 2026-03-31 · Number of holdings: 167
Bellevue Group AG disclosed 167 holdings in its latest 13F filing for the period ending 2026-03-31, with total reported value of $4.2B and a quarterly turnover rate of 66.6%.
Browse other institutions with $1B to $10B AUMBrowse other institutions starting with "B"
Bellevue Group AG's disclosed holdings carry a Herfindahl concentration index of 0.028 — mathematically equivalent to about 36 equally-sized positions, well below its 167 actual disclosed holdings. That gap points to a strategy built around a small core of high-conviction bets rather than broad diversification.
Position sizes vary widely across the portfolio (a coefficient of variation of 1.83), with a handful of outsized bets alongside many smaller positions.
No strong tilt toward either adding to existing winners or initiating outsized new positions was observed in the latest reported quarter.
Sector classification currently covers about 67% of this portfolio's disclosed value; the remainder includes holdings (e.g. unmapped tickers, options, or other security types) not yet covered by our sector mapping.
Add REGN
+1900.8% $204.6M
Trim NBIX
-99.7% -$241.0M
Trim RVMD
-69.1% -$248.5M
Trim IONS
-62.1% -$243.3M
Add GILD
+2117.7% $156.6M
Add CRNX
+81088.1% $118.9M
Showing top 155 holdings (of 167 total)
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | VRTX | Vertex Pharmaceuticals INC | Stock-Healthcare | 7.25% | — | +0.12% | |
| 2 | ARGX | Argenx Se - Adr | Stock-Healthcare | 5.44% | -1.92% | -32.23% | |
| 3 | REGN | Regeneron Pharmaceuticals | Stock-Healthcare | 5.12% | +4.92% | +1900.82% | |
| 4 | SRRK | Scholar Rock Holding CORP | Stock-Other | 4.19% | — | -11.64% | |
| 5 | GILD | Gilead Sciences INC | Stock-Healthcare | 3.88% | +3.76% | +2117.70% | |
| 6 | RVMD | Revolution Medicines INC | Stock-Healthcare | 3.57% | -3.99% | -69.15% | |
| 7 | IONS | Ionis Pharmaceuticals INC | Stock-Healthcare | 3.25% | -3.95% | -62.13% | |
| 8 | ISRG | Intuitive Surgical INC | Stock-Healthcare | 3.14% | -0.32% | -10.98% | |
| 9 | VRDN | Viridian Therapeutics INC | Stock-Other | 3.13% | — | +54.32% | |
| 10 | KRYS | Krystal Biotech INC | Stock-Healthcare | 2.96% | +1.04% | +17.42% | |
| 11 | CRNX | Crinetics Pharmaceuticals In | Stock-Other | 2.84% | +2.84% | +81088.12% | |
| 12 | ABT | Abbott Laboratories | Stock-Healthcare | 2.81% | -0.32% | -12.55% | |
| 13 | NUVL | Nuvalent Inc-a | Stock-Other | 2.57% | — | +1.52% | |
| 14 | AMGN | Amgen INC | Stock-Healthcare | 2.47% | +2.36% | +1497.48% | |
| 15 | BSX | Boston Scientific CORP | Stock-Healthcare | 2.19% | -0.63% | -5.94% | |
| 16 | ELVN | Enliven Therapeutics INC | Stock-Other | 2.17% | +2.17% | NEW | |
| 17 | IMCR | Immunocore Holdings Plc-adr | Stock-Other | 2.01% | +0.17% | — | |
| 18 | MDT | Medtronic plc | Stock-Healthcare | 1.97% | +0.57% | +24.88% | |
| 19 | ALNY | Alnylam Pharmaceuticals INC | Stock-Healthcare | 1.85% | -1.51% | -47.40% | |
| 20 | RLAY | Relay Therapeutics INC | Stock-Other | 1.85% | — | -6.59% | |
| 21 | SYK | Stryker CORP | Stock-Healthcare | 1.70% | -0.70% | -39.75% | |
| 22 | PCVX | Vaxcyte INC | Stock-Other | 1.65% | +1.65% | NEW | |
| 23 | VERA | Vera Therapeutics INC | Stock-Other | 1.64% | +0.01% | +0.74% | |
| 24 | EW | Edwards Lifesciences CORP | Stock-Healthcare | 1.60% | -0.09% | -19.52% | |
| 25 | DMRA | Damora Therapeutics INC | Stock-Other | 1.42% | +1.42% | NEW | |
| 26 | TNGX | Tango Therapeutics INC | Stock-Other | 1.19% | +0.53% | -38.90% | |
| 27 | IDXX | Idexx Laboratories INC | Stock-Healthcare | 1.19% | -0.02% | -5.72% | |
| 28 | RARE | Ultragenyx Pharmaceutical In | Stock-Other | 1.19% | +1.19% | +92148.06% | |
| 29 | DXCM | Dexcom INC | Stock-Healthcare | 1.18% | — | -6.92% | |
| 30 | JBIO | Jade Biosciences INC | Stock-Other | 1.17% | — | +4.80% | |
| 31 | EWTX | Edgewise Therapeutics INC | Stock-Other | 1.15% | +0.43% | — | |
| 32 | UNH | Unitedhealth Group INC | Stock-Healthcare | 0.95% | -0.15% | -15.39% | |
| 33 | DHR | Danaher CORP | Stock-Healthcare | 0.91% | — | +3.87% | |
| 34 | CLDX | Celldex Therapeutics INC | Stock-Other | 0.91% | -0.95% | -66.83% | |
| 35 | RMD | Resmed INC | Stock-Healthcare | 0.85% | — | -1.16% | |
| 36 | PODD | Insulet CORP | Stock-Healthcare | 0.82% | -0.19% | -12.34% | |
| 37 | TMO | Thermo Fisher Scientific INC | Stock-Healthcare | 0.75% | — | -1.02% | |
| 38 | LLY | Eli Lilly & Co | Stock-Healthcare | 0.74% | — | -0.21% | |
| 39 | GEHC | GE Healthcare Technology | Stock-Healthcare | 0.71% | — | -1.80% | |
| 40 | IRON | Disc Medicine INC | Stock-Other | 0.70% | +0.70% | NEW | |
| 41 | JNJ | Johnson & Johnson | Stock-Healthcare | 0.69% | — | -6.07% | |
| 42 | ANNX | Annexon INC | Stock-Other | 0.68% | — | — | |
| 43 | CI | THE Cigna Group | Stock-Healthcare | 0.62% | — | -10.68% | |
| 44 | ORKA | Oruka Therapeutics INC | Stock-Other | 0.59% | +0.59% | NEW | |
| 45 | MRK | Merck & Co. INC. | Stock-Healthcare | 0.59% | +0.41% | +124.27% | |
| 46 | ALGN | Align Technology INC | Stock-Healthcare | 0.57% | — | -1.27% | |
| 47 | STE | STERIS plc | Stock-Healthcare | 0.53% | — | -1.80% | |
| 48 | GMED | Globus Medical INC - A | Stock-Healthcare | 0.51% | — | -5.87% | |
| 49 | GLUE | Monte Rosa Therapeutics INC | Stock-Other | 0.49% | +0.49% | NEW | |
| 50 | ABBV | Abbvie INC | Stock-Healthcare | 0.48% | -0.10% | -30.62% |
Performance for Q3 2026
+18.1%
Performance Last 4 Quarters
+36.5%
Based on 70% of reported portfolio value with available pricing
| Period | Holdings | Total value | Stability | Top holdings |
|---|---|---|---|---|
| 2026-03-31 | 167 | $4.2B | 67 | |
| 2025-12-31 | 213 | $5.3B | 44 | |
| 2025-09-30 | 186 | $4.8B | 35 | |
| 2025-06-30 | 175 | $4.5B | 0 | |
| 2025-03-31 | 177 | $4.5B | 100 | |
| 2024-12-31 | 193 | $5.2B | 0 | |
| 2024-09-30 | 196 | $6.2B | 0 | |
| 2024-06-30 | 204 | $6.2B | 0 | |
| 2024-03-31 | 208 | $6.6B | 0 | |
| 2023-12-31 | 202 | $6.5B | 0 | |
| 2023-09-30 | 196 | $6.2B | 0 | |
| 2023-06-30 | 198 | $7.0B | 0 | |
| 2023-03-31 | 202 | $6.9B | 0 | |
| 2022-12-31 | 215 | $7.5B | 0 | |
| 2022-09-30 | 217 | $7.0B | 0 | |
| 2022-06-30 | 214 | $7.1B | 0 | |
| 2022-03-31 | 220 | $8.6B | 0 | |
| 2021-12-31 | 235 | $9.7B | 0 | |
| 2021-09-30 | 265 | $9.9B | 0 | |
| 2021-06-30 | 262 | $10.2B | 96 | |
| 2021-03-31 | 260 | $9.5B | 22 | |
| 2020-12-31 | 266 | $8.7B | 35 | |
| 2020-09-30 | 261 | $7.2B | 21 | |
| 2020-06-30 | 235 | $7.1B | 37 | |
| 2020-03-31 | 239 | $5.2B | 29 | |
| 2019-12-31 | 239 | $6.3B | 35 | |
| 2019-09-30 | 236 | $5.4B | 20 | |
| 2019-06-30 | 219 | $5.9B | 100 | |
| 2019-03-31 | 138 | $1.8B | 40 | |
| 2018-12-31 | 138 | $1.5B | 35 | |
| 2018-09-30 | 138 | $1.6B | 34 | |
| 2018-06-30 | 138 | $1.2B | 33 | |
| 2018-03-31 | 124 | $1.0B | 30 | |
| 2017-12-31 | 134 | $957.2M | 30 | |
| 2017-09-30 | 131 | $956.1M | 28 | |
| 2017-06-30 | 132 | $845.7M | 32 | |
| 2017-03-31 | 132 | $750.4M | 49 | |
| 2016-12-31 | 122 | $488.3M | 28 | |
| 2016-09-30 | 121 | $553.5M | 26 | |
| 2016-06-30 | 124 | $531.5M | 43 | |
| 2016-03-31 | 130 | $551.1M | 0 |
Bellevue Group AG's most significant position changes for 2026-03-31: Sold out: Avidity Biosciences INC (RNAGBP); Sold out: Amicus Therapeutics INC (AM6); New buy: Enliven Therapeutics INC (ELVN); New buy: Vaxcyte INC (PCVX); New buy: Damora Therapeutics INC (DMRA).
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | REGN | Regeneron Pharmaceuticals | +4.9% | +1900.82% | Add |
| 2 | GILD | Gilead Sciences INC | +3.8% | +2117.70% | Add |
| 3 | CRNX | Crinetics Pharmaceuticals In | +2.8% | +81088.12% | Add |
| 4 | AMGN | Amgen INC | +2.4% | +1497.48% | Add |
| 5 | RARE | Ultragenyx Pharmaceutical In | +1.2% | +92148.06% | Add |
| 6 | KRYS | Krystal Biotech INC | +1% | +17.42% | Add |
| 7 | MDT | Medtronic plc | +0.6% | +24.88% | Add |
| 8 | TNGX | Tango Therapeutics INC | +0.5% | -38.90% | Trim |
| 9 | EWTX | Edgewise Therapeutics INC | +0.4% | — | Unchanged |
| 10 | MRK | Merck & Co. INC. | +0.4% | +124.27% | Add |
| 11 | IMCR | Immunocore Holdings Plc-adr | +0.2% | — | Unchanged |
| 12 | VERA | Vera Therapeutics INC | 0% | +0.74% | Add |
| 13 | IDXX | Idexx Laboratories INC | 0% | -5.72% | Trim |
| 14 | HUM | Humana INC | -0.1% | -11.74% | Trim |
| 15 | ZBH | Zimmer Biomet Holdings INC | -0.1% | -34.82% | Trim |
| 16 | EW | Edwards Lifesciences CORP | -0.1% | -19.52% | Trim |
| 17 | ELV | Elevance Health INC | -0.1% | -24.59% | Trim |
| 18 | ABBV | Abbvie INC | -0.1% | -30.62% | Trim |
| 19 | VEEV | Veeva Systems Inc-class A | -0.1% | -29.82% | Trim |
| 20 | UNH | Unitedhealth Group INC | -0.2% | -15.39% | Trim |
| 21 | GPCR | Structure Therapeutics INC | -0.2% | -95.31% | Trim |
| 22 | IQV | Iqvia Holdings INC | -0.2% | -98.21% | Trim |
| 23 | PODD | Insulet CORP | -0.2% | -12.34% | Trim |
| 24 | GKOS | Glaukos CORP | -0.2% | -44.37% | Trim |
| 25 | MASI* | Masimo CORP | -0.2% | -91.00% | Trim |
| 26 | ISRG | Intuitive Surgical INC | -0.3% | -10.98% | Trim |
| 27 | ABT | Abbott Laboratories | -0.3% | -12.55% | Trim |
| 28 | WVE | Wave Life Sciences Ltd. | -0.5% | -99.65% | Trim |
| 29 | BDX | Becton Dickinson And Co | -0.5% | -54.12% | Trim |
| 30 | BSX | Boston Scientific CORP | -0.6% | -5.94% | Trim |
| 31 | SYK | Stryker CORP | -0.7% | -39.75% | Trim |
| 32 | PEN | Penumbra INC | -0.7% | -90.94% | Trim |
| 33 | CLDX | Celldex Therapeutics INC | -1% | -66.83% | Trim |
| 34 | ALNY | Alnylam Pharmaceuticals INC | -1.5% | -47.40% | Trim |
| 35 | ARGX | Argenx Se - Adr | -1.9% | -32.23% | Trim |
| 36 | IONS | Ionis Pharmaceuticals INC | -4% | -62.13% | Trim |
| 37 | RVMD | Revolution Medicines INC | -4% | -69.15% | Trim |
| 38 | NBIX | Neurocrine Biosciences INC | -4.6% | -99.73% | Trim |
| 39 | RNAGBP | Avidity Biosciences INC | — | EXIT | Sold out |
| 40 | AM6 | Amicus Therapeutics INC | — | EXIT | Sold out |
| 41 | ELVN | Enliven Therapeutics INC | — | NEW | New buy |
| 42 | PCVX | Vaxcyte INC | — | NEW | New buy |
| 43 | DMRA | Damora Therapeutics INC | — | NEW | New buy |
| 44 | MAZE | Maze Therapeutics INC | — | EXIT | Sold out |
| 45 | IRON | Disc Medicine INC | — | NEW | New buy |
| 46 | ORKA | Oruka Therapeutics INC | — | NEW | New buy |
| 47 | GLUE | Monte Rosa Therapeutics INC | — | NEW | New buy |
| 48 | LIVN | LivaNova PLC | — | NEW | New buy |
| 49 | CDNA | Caredx INC | — | EXIT | Sold out |
| 50 | MOH | Molina Healthcare INC | — | EXIT | Sold out |
| Period | Filed | Type | EDGAR |
|---|---|---|---|
| 2026-03-31 | 2026-05-15 | 13F-HR | View on EDGAR |
| 2025-12-31 | 2026-02-17 | 13F-HR | View on EDGAR |
| 2025-09-30 | 2025-11-14 | 13F-HR | View on EDGAR |
| 2025-06-30 | 2025-08-14 | 13F-HR | View on EDGAR |
| 2025-03-31 | 2025-05-14 | 13F-HR | View on EDGAR |
| 2024-12-31 | 2025-02-14 | 13F-HR | View on EDGAR |
| 2024-09-30 | 2024-11-14 | 13F-HR | View on EDGAR |
| 2024-06-30 | 2024-08-14 | 13F-HR | View on EDGAR |
| 2024-03-31 | 2024-05-15 | 13F-HR | View on EDGAR |
| 2023-12-31 | 2024-02-14 | 13F-HR | View on EDGAR |
| 2023-09-30 | 2023-11-14 | 13F-HR | View on EDGAR |
| 2023-06-30 | 2023-08-14 | 13F-HR | View on EDGAR |
| 2023-03-31 | 2023-05-15 | 13F-HR | View on EDGAR |
| 2022-12-31 | 2023-02-14 | 13F-HR | View on EDGAR |
| 2022-09-30 | 2022-11-14 | 13F-HR | View on EDGAR |
| 2022-06-30 | 2022-08-11 | 13F-HR | View on EDGAR |
| 2022-03-31 | 2022-05-13 | 13F-HR | View on EDGAR |
| 2021-12-31 | 2022-02-10 | 13F-HR | View on EDGAR |
| 2021-09-30 | 2021-11-12 | 13F-HR | View on EDGAR |
| 2021-06-30 | 2021-08-12 | 13F-HR | View on EDGAR |
| 2021-03-31 | 2021-05-12 | 13F-HR | View on EDGAR |
| 2020-12-31 | 2021-02-16 | 13F-HR | View on EDGAR |
| 2020-09-30 | 2020-11-16 | 13F-HR | View on EDGAR |
| 2020-06-30 | 2020-08-13 | 13F-HR | View on EDGAR |
| 2020-03-31 | 2020-05-14 | 13F-HR | View on EDGAR |
| 2019-12-31 | 2020-02-14 | 13F-HR | View on EDGAR |
| 2019-09-30 | 2019-11-14 | 13F-HR | View on EDGAR |
| 2019-06-30 | 2019-08-14 | 13F-HR | View on EDGAR |
| 2019-03-31 | 2019-05-15 | 13F-HR | View on EDGAR |
| 2018-12-31 | 2019-02-12 | 13F-HR | View on EDGAR |
| 2018-09-30 | 2018-11-13 | 13F-HR | View on EDGAR |
| 2018-06-30 | 2018-08-07 | 13F-HR | View on EDGAR |
| 2018-03-31 | 2018-05-09 | 13F-HR | View on EDGAR |
| 2017-12-31 | 2018-02-14 | 13F-HR | View on EDGAR |
| 2017-09-30 | 2017-11-13 | 13F-HR | View on EDGAR |
| 2017-06-30 | 2017-08-14 | 13F-HR | View on EDGAR |
| 2017-03-31 | 2017-05-11 | 13F-HR | View on EDGAR |
| 2016-12-31 | 2017-02-10 | 13F-HR | View on EDGAR |
| 2016-09-30 | 2016-11-10 | 13F-HR | View on EDGAR |
| 2016-06-30 | 2016-08-12 | 13F-HR | View on EDGAR |
| 2016-03-31 | 2016-05-16 | 13F-HR | View on EDGAR |
Institutions with a similar AUM
CIK 0000900974
Total reported value
$4.2B
2,009 stks
2026-03-31
AUM within 0.2% of this institution
CIK 0001841616
Total reported value
$4.2B
506 stks
2024-03-31
Stale — no recent filing
AUM within 0.3% of this institution
CIK 0001713662
Total reported value
$4.2B
1,202 stks
2026-03-31
AUM within 0.4% of this institution
Institutions with overlapping top holdings
CIK 0000019481
Total reported value
$362.5M
450 stks
2026-03-31
3 of the top 5 holdings overlap, including Gilead Sciences INC
CIK 0001300336
Total reported value
$2.6B
166 stks
2023-06-30
Stale — no recent filing
3 of the top 5 holdings overlap, including Gilead Sciences INC
CIK 0001642343
Total reported value
$656.3M
127 stks
2015-12-31
Stale — no recent filing
2 of the top 5 holdings overlap, including Gilead Sciences INC